<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01398553</url>
  </required_header>
  <id_info>
    <org_study_id>Gesundheitsbezirk Bozen</org_study_id>
    <nct_id>NCT01398553</nct_id>
  </id_info>
  <brief_title>Automated Versus Standard Physiotherapy for Upper Limb Rehabilitation in Patients With Acquired Brain Lesions</brief_title>
  <official_title>Armeo® Versus Standard Physiotherapy for Upper Limb Rehabilitation in Patients With Acquired Brain Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Krankenhaus Bozen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Valduce Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Krankenhaus Bozen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Armeo Spring has proven its effectiveness in the rehabilitation of acute stroke patients.
      It neutralizes limb weight, enabling patients to use residual control in both arm and hand
      and to follow exercises guided by simulations of real-life challenges. The Armeo Spring
      incorporates wrist pronation and supination, allowing patients to enhance functional reaching
      patterns.

      Aim of the study is to compare the Armeo device with standard physiotherapy in chronic
      patients with acquired brain lesions.

      The result of the trial should show which treatment is more effective in the clinical
      practice. A significant better outcome of one arm should suggest to follow one treatment
      strategy more than the other.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    the human resources in the organisation are to limited to do the trial
  </why_stopped>
  <start_date>March 2011</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fugl Meyer Score for sensorymotor recovery of the upper limb after stroke</measure>
    <time_frame>Enrollment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Fugl Meyer Score for sensorymotor recovery of the upper limb after stroke</measure>
    <time_frame>Baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Fugl Meyer Score for sensorymotor recovery of the upper limb after stroke</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Fugl Meyer Score for sensorymotor recovery of the upper limb after stroke</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Fugl Meyer Score for sensorymotor recovery of the upper limb after stroke</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Upper Extremity Motor Activity Log for measuring real use of the upper limb</measure>
    <time_frame>Enrolment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Upper Extremity Motor Activity Log for measuring real use of the upper limb</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Upper Extremity Motor Activity Log for measuring real use of the upper limb</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Upper Extremity Motor Activity Log for measuring real use of the upper limb</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Upper Extremity Motor Activity Log for measuring real use of the upper limb</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wolf Motor Function Test for measurement of timed joint-segment movements</measure>
    <time_frame>Enrolment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wolf Motor Function Test for measurement of timed joint-segment movements</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wolf Motor Function Test for measurement of timed joint-segment movements</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wolf Motor Function Test for measurement of timed joint-segment movements</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wolf Motor Function Test for measurement of timed joint-segment movements</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Global Impression Score for the measurement of change over time of the illness' severity</measure>
    <time_frame>Enrolment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Global Impression Score for the measurement of change over time of the illness' severity</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Global Impression Score for the measurement of change over time of the illness' severity</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Global Impression Score for the measurement of change over time of the illness' severity</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Global Impression Score for the measurement of change over time of the illness' severity</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Vascular Accident, Brain</condition>
  <condition>Traumatic Brain Injury</condition>
  <arm_group>
    <arm_group_label>Armeo Spring</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional physiotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Armeo Spring</intervention_name>
    <description>30min Armeo Spring + 15min task oriented therapy over 6 weeks Frequency: 3 x/week</description>
    <arm_group_label>Armeo Spring</arm_group_label>
    <other_name>group A</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>conventional physiotherapy</intervention_name>
    <description>30min occupational therapy(15min ADL-training, 15min repetitive training) + 15min task oriented therapy over 6 weeks Frequency: 3x/week</description>
    <arm_group_label>conventional physiotherapy</arm_group_label>
    <other_name>group B</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  6 month after the onset of disease

          -  acquired brain lesions in adults with upper limb hemiparesis

          -  modified Ashworth &lt;= 3

          -  muscular strength MRC =&gt;1 mano; MRC =&gt;2 elbow e shoulder

          -  Fugl Meyer =&gt; 18

        Exclusion Criteria:

          -  NYHA &gt;III

          -  MMSE (mini mental status examination test) &lt; 24

          -  muscular strength (MRC) &lt; 1

          -  Dystonia, spasticity (Ashworth =&gt; 3)

          -  articular contractions in the upper limb

          -  previous upper limb lesions

          -  cognitive/language impairment likely to influence assessments

          -  any diagnosis likely to interfere with rehabilitation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Zelger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Krankenhaus Bozen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Franco Molteni, MD</last_name>
    <role>Study Director</role>
    <affiliation>Valduce Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elisabeth Hofer, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Krankenhaus Bozen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mauro Rossini, MSc</last_name>
    <role>Study Chair</role>
    <affiliation>Valduce Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Valduce Hospital</name>
      <address>
        <city>Costa Masnaga</city>
        <state>Lombardia</state>
        <zip>23845</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Bozen</name>
      <address>
        <city>Bozen</city>
        <state>Südtirol</state>
        <zip>39100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <link>
    <url>http://asbz.it</url>
    <description>Study Sponsor</description>
  </link>
  <link>
    <url>http://www.valduce.it</url>
    <description>Participating Centre</description>
  </link>
  <reference>
    <citation>Kwakkel G, Kollen BJ, Krebs HI. Effects of robot-assisted therapy on upper limb recovery after stroke: a systematic review. Neurorehabil Neural Repair. 2008 Mar-Apr;22(2):111-21. Epub 2007 Sep 17. Review.</citation>
    <PMID>17876068</PMID>
  </reference>
  <reference>
    <citation>Prange GB, Jannink MJ, Groothuis-Oudshoorn CG, Hermens HJ, Ijzerman MJ. Systematic review of the effect of robot-aided therapy on recovery of the hemiparetic arm after stroke. J Rehabil Res Dev. 2006 Mar-Apr;43(2):171-84. Review.</citation>
    <PMID>16847784</PMID>
  </reference>
  <reference>
    <citation>Lam P, Hebert D, Boger J, Lacheray H, Gardner D, Apkarian J, Mihailidis A. A haptic-robotic platform for upper-limb reaching stroke therapy: preliminary design and evaluation results. J Neuroeng Rehabil. 2008 May 22;5:15. doi: 10.1186/1743-0003-5-15.</citation>
    <PMID>18498641</PMID>
  </reference>
  <reference>
    <citation>Masiero S, Celia A, Rosati G, Armani M. Robotic-assisted rehabilitation of the upper limb after acute stroke. Arch Phys Med Rehabil. 2007 Feb;88(2):142-9.</citation>
    <PMID>17270510</PMID>
  </reference>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 29, 2010</study_first_submitted>
  <study_first_submitted_qc>July 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2011</study_first_posted>
  <last_update_submitted>September 5, 2016</last_update_submitted>
  <last_update_submitted_qc>September 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>stroke</keyword>
  <keyword>tbi</keyword>
  <keyword>rehabilitation</keyword>
  <keyword>upper limb</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

